Announcements Trials
Browse Landscape

Phase

Phase NA 41Phase 2 4Phase 3 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Recruiting 9Active not recruiting 5Completed 4Terminated 2

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Stomatitis 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × Practice Guidelines as Topic × Clear all
NCT03745794 2025-12-23

Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery

M.D. Anderson Cancer Center

Phase 2 Completed
136 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

NCT04205955 2024-05-01

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

SWOG Cancer Research Network

Phase 2 Completed
95 enrolled 30 charts
Gastrointestinal

Rectal Neoplasms

NCT04496219 2024-01-02

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Fred Hutchinson Cancer Center

Phase 2 Completed
45 enrolled 16 charts
Genitourinary

Urinary Bladder Neoplasms

NCT03469284 2023-04-25

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

M.D. Anderson Cancer Center

Phase 2 Completed
69 enrolled 11 charts

Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡